Showing results (161-170 of 9,915) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|May 10, 2023
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Giuliano Filippini Velázquez, Myriam Labopin, Johanna Tischer, et al.Bone Marrow Transplantation|July 7, 2015
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathyK Balassa, H Andrikovics, P Remenyi, et al.Bone Marrow Transplantation|June 30, 2015
Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantationN Alam, E G Atenafu, J Kuruvilla, et al.Bone Marrow Transplantation|July 14, 2015
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphomaS Yano, T Mori, Y Kanda, et al.Bone Marrow Transplantation|June 4, 2015
T-cell depletion: from positive selection to negative depletion in adult patientsF AversaBone Marrow Transplantation|June 4, 2015
The role of donor-derived veto cells in nonmyeloablative haploidentical HSCTN Or-Geva, Y ReisnerBone Marrow Transplantation|June 4, 2015
T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cellsR J O'Reilly, G Koehne, A N Hasan, et al.Bone Marrow Transplantation|June 4, 2015
Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patientsP Lang, T Feuchtinger, H-M Teltschik, et al.Bone Marrow Transplantation|June 4, 2015
Sex steroid ablation: an immunoregenerative strategy for immunocompromised patientsE Velardi, J A Dudakov, M R M van den BrinkBone Marrow Transplantation|July 21, 2015
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantationS Fu, L Rybicki, D Abounader, et al.Pageof 992